Merck KGaA (MKKGY) – What Are Investment Firms Saying About This Stock?

Shares of Merck KGaA (OTCMKTS:MKKGY – Get Free Report) have been given a consensus recommendation of “Reduce” by the six brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have assigned a hold recommendation to the company.

MKKGY has been the topic of several analyst reports. HSBC raised shares of Merck KGaA to a “hold” rating in a report on Monday, July 6th. UBS Group downgraded shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Finally, Zacks Research lowered shares of Merck KGaA from a “hold” rating to a “strong sell” rating in a research report on Monday, October 12th.

Get Our Latest Stock Analysis on Merck KGaA

Merck KGaA Stock Performance

MKKGY stock traded up $0.20 during midday trading on Friday, hitting $32.27. The stock had a trading volume of 113,186 shares, compared to its average volume of 83,126. The firm has a market capitalization of $20.85 billion, a price-to-earnings ratio of 16.63, a P/E/G ratio of 3.03 and a beta of 0.95. Merck KGaA has a 52 week low of $23.73 and a 52 week high of $34.19. The stock has a 50-day simple moving average of $31.41 and a 200 day simple moving average of $30.35. The company has a current ratio of 1.69, a quick ratio of 1.09 and a debt-to-equity ratio of 0.37.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. The company operates independently from Merck & Co, Inc, the U.S.-based company that uses the Merck name in the United States and Canada.

Merck KGaA operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, analytical technologies and bioprocessing solutions used by pharmaceutical and biotechnology companies, academic institutions and industrial laboratories.

Further Reading

Analyst Recommendations for Merck KGaA (OTCMKTS:MKKGY)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.